ResearcherUniversity of PennsylvaniaActive in the last 2 years

Jayne C. McDevitt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5261-394X; OpenAlex author ID A5079342695; NIH RePORTER profile ID 79926126. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper · 2026: 1 grant

Papers 1

T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-24-1475 ↗

Grants 1

Clonal dynamics and non-genetic mechanisms mediating resistance to RAS inhibition F31CA310236 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Samantha B. Kemp · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Margo Orlen · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Ben Z. Stanger · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Robert H. Vonderheide · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Mallika Singh · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.